Niowave, Inc

Niowave is a domestic supplier of medical and industrial radioisotopes from uranium fission and stable targets. Isotope inventories available for purchase include alpha, beta, and gamma sources. The system uses a superconducting linac instead of a nuclear reactor which is simpler to operate and less costly to license. It also eliminates the need for a nuclear reactor and weapons grade uranium (HEU). The small batch radiochemistry operations can be automated, and do not require licensing as a nuclear reprocessing facility. Isotope production and distribution utilize existing radiopharmaceutical supply chain and FDA approval processes

Niobium,particle accelerators,and radioisotopes

Niowave, inc operates in the Pharmaceutical manufacturing industry.

Niowave, inc's revenue is 11m - 100m

Niowave, inc has 51 - 200 employees.